BACKGROUND: Endothelial malignancies, such as angiosarcoma and hemangioendothelioma, are often resistant to chemotherapy and surgery, and may result in death. Improved means of therapy are needed for these disorders. OBJECTIVE: We wanted to determine whether angiosarcoma can be treated with angiogenesis inhibitors in mice. METHODS: Mice were inoculated with a cell line that gives rise to angiosarcoma and were treated with the angiogenesis inhibitors 2-methoxyestradiol and TNP-470. Response to therapy was monitored by measurement of tumors. RESULTS: TNP-470 caused an 84% reduction in tumor size, and 2-methoxyestradiol caused a 68% reduction in tumor size. CONCLUSION: Angiogenesis inhibitors are highly effective in treatment of angiosarcoma in mice. Clinical trials of these agents in humans with angiosarcoma and hemangioendothelioma are warranted.
BACKGROUND: Endothelial malignancies, such as angiosarcoma and hemangioendothelioma, are often resistant to chemotherapy and surgery, and may result in death. Improved means of therapy are needed for these disorders. OBJECTIVE: We wanted to determine whether angiosarcoma can be treated with angiogenesis inhibitors in mice. METHODS:Mice were inoculated with a cell line that gives rise to angiosarcoma and were treated with the angiogenesis inhibitors 2-methoxyestradiol and TNP-470. Response to therapy was monitored by measurement of tumors. RESULTS: TNP-470 caused an 84% reduction in tumor size, and 2-methoxyestradiol caused a 68% reduction in tumor size. CONCLUSION: Angiogenesis inhibitors are highly effective in treatment of angiosarcoma in mice. Clinical trials of these agents in humans with angiosarcoma and hemangioendothelioma are warranted.
Authors: Franck Amblard; Baskaran Govindarajan; Benjamin Lefkove; Kimberly L Rapp; Mervi Detorio; Jack L Arbiser; Raymond F Schinazi Journal: Bioorg Med Chem Lett Date: 2007-06-10 Impact factor: 2.823
Authors: Sulochana S Bhandarkar; Jacqueline Bromberg; Carol Carrillo; Ponniah Selvakumar; Rajendra K Sharma; Betsy N Perry; Baskaran Govindarajan; Levi Fried; Allie Sohn; Kalpana Reddy; Jack L Arbiser Journal: Clin Cancer Res Date: 2008-09-15 Impact factor: 12.531
Authors: Shelley A Gestl; Mitchell D Green; Debra A Shearer; Elizabeth Frauenhoffer; Thomas R Tephly; Judith Weisz Journal: Am J Pathol Date: 2002-04 Impact factor: 4.307
Authors: Amye J Tevaarwerk; Kyle D Holen; Dona B Alberti; Carolyn Sidor; Jamie Arnott; Check Quon; George Wilding; Glenn Liu Journal: Clin Cancer Res Date: 2009-02-15 Impact factor: 12.531
Authors: Jack L Arbiser; Tweeny Kau; Martha Konar; Krishna Narra; Ramani Ramchandran; Scott A Summers; Chris J Vlahos; Keqiang Ye; Betsy N Perry; William Matter; Anthony Fischl; James Cook; Pamela A Silver; Jenny Bain; Philip Cohen; David Whitmire; Scott Furness; Baskaran Govindarajan; J Phillip Bowen Journal: Blood Date: 2006-09-21 Impact factor: 22.113